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Mass spectrometry of charged derivatives of peptides has been a growing area of interest in the
past decade. Fragmentation of charged derivatives of peptides is believed to be different from
than that of protonated peptides when analyzed by collisionally activated dissociation-tandem
mass spectrometry (CAD-MS/MS). The charged derivatives fragment by charge-remote
fragmentation mechanisms, which are usually classified as high-energy (HE)-CAD processes.
Our objective in the present study is to investigate the mechanism of fragmentation of charged
derivatives of peptides when analyzed by matrix-assisted laser desorption/ionization-post-
source decay-mass spectrometry (MALDI-PSD-MS) and electrospray ionization (ESI)-CAD-
MS/MS (ion trap), which involve low-energy processes. Three major types of hydrogens (a, b,
and amide) are available for migration during the formation of the *an ions (the predominant
ion series produced from these charged derivatives). To pinpoint which of the three hydrogens
is involved in the formation of the *an ions, deuterium-labeled peptide derivatives with labels
at specific sites were synthesized and analyzed by MALDI-PSD-MS and ESI-CAD-MS/MS.
Our results suggest that the amide hydrogen of the residue at which the cleavage occurs shifts
during the formation of *an; this observation serves as evidence for the mechanism proposed
earlier by Liao et al. for fragmentation of such charged derivatives. The results also help
elucidate the structure of the *an ions, *bn ions, and others formed during cleavage at the
proline residue, as well as the ions formed during loss of the C-terminal residue from these
charged derivatives. (J Am Soc Mass Spectrom 2001, 12, 399–409) © 2001 American Society
for Mass Spectrometry
In mass spectrometry, structural information for apeptide after ionization and desorption into the gasphase is typically obtained by m/z analysis of frag-
ments following collisionally activated dissociation
(CAD) of selected ions. Roepstorff and Fohlmann [1]
introduced nomenclature using capital letters (e.g., B,
Y) to conceptually represent ions formed by cleavage of
designated bonds in the peptide backbone; Biemann [2]
modified this nomenclature using lower case letters
(e.g., b, y) to represent the elemental composition of the
actual ions formed (e.g., y 5 Y 1 2H). Fragmentation
of charged derivatives of peptides is believed to be
different from than that of protonated peptides when
analyzed by CAD tandem mass spectrometry (MS/MS).
Charged derivatives fragment by charge-remote frag-
mentation mechanisms, which are usually classified as
high-energy (HE)-CAD processes. Our objective in the
present study is to investigate the mechanism of frag-
mentation of charged derivatives of peptides when
analyzed by matrix-assisted laser desorption/ionization-
postsource decay-mass spectrometry (MALDI-PSD-MS)
and electrospray ionization (ESI)-CAD-MS/MS (ion trap),
which involve low-energy processes. Three major types of
hydrogens (a, b, and amide) are available for migration
during the formation of the *an ions (the predominant ion
series produced from these charged derivatives). To pin-
point which of the three hydrogens is involved in the
formation of the *an ions, deuterium-labeled peptide deriv-
atives with labels at specific sites were synthesized and
analyzed by MALDI-PSD-MS and ESI-CAD-MS/MS. Our
results suggest that the amide hydrogen of the residue at
which the cleavage occurs shifts during the formation of *an;
this observation serves as evidence for the mechanism pro-
posed earlier by Liao et al. for fragmentation of such charged
derivatives. The results also help elucidate the structure of
the *an ions, *bn ions, and others formed during cleavage at
the proline residue, as well as the ions formed during loss of
the C-terminal residue from these charged derivatives.
Perspective on Fragmentation of
Protonated Peptides during CAD
Several mechanisms have been proposed for fragmen-
tation of protonated peptides; of these, the “mobile-
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proton model” is widely accepted [3]. The mobile
proton model, which suggests random protonation of
the backbone amide groups, has been supported by
deuterium exchange studies performed by Johnson et
al. [4]. During ESI, singly or multiply charged ions are
formed with the protons initially located on the same
functional group (the amino terminus or the basic
sidechain) as they were in aqueous solution. However,
in the gas phase, these protons are free to transfer to the
amides, where they may induce cleavage [5]. The paper
by McCormack et al. suggests that protonation of the
amide nitrogen significantly weakens the amide bond
relative to that in the neutral species [6]. When the
collection of peptides, protonated at various amide loca-
tions, is subjected to CAD, some of the kinetic energy is
converted to vibrational energy and many of the ions
suffer fragmentation at the protonated amide bond.
In 1986, Hunt et al. proposed mechanisms and struc-
tures for various fragment ions formed from protonated
peptides based on fast-atom bombardment (FAB) low-
energy CAD-MS/MS studies [7]. They suggested that
the yn ion (Yn 1 2) ion receives one of its hydrogens
from the FAB matrix, whereas the other hydrogen shifts
from the a-carbon of the amino acid residue (b with
respect to the protonated amide nitrogen). Mueller et al.
performed the first deuterium labeling studies in 1988
by FAB-CAD-MS/MS to pinpoint the origin of the
shifting hydrogens resulting in the formation of the yn
ion [8]. The hydrogen on the amide nitrogens and the
terminal groups were labeled with deuterium in this
hydrogen/deuterium exchange study. These studies
proved that the exchangeable amide hydrogen rather
than the hydrogen from the a-carbon is transferred to
the yn fragment. Later, Kenny et al. (1992) performed
studies that involved labeling of the a-carbon with
deuterium using FAB-high-energy CAD-MS/MS [9].
Results from their studies also were in agreement with
those of Mueller et al. showing that it is the migration of
the hydrogen from an amide nitrogen, rather than from
an a-carbon, that results in the formation of the yn ion.
Hunt et al. also proposed a charge-site induced
a-cleavage mechanism for the formation of the *bn ion,
the N-terminal counterpart of the yn ion, resulting from
the cleavage of the amide bond [7]. Figure 1a,b depicts
the previously proposed mechanisms for the formation
of the yn and the bn ions, respectively.
These mechanisms require protonation of an amide
bond before cleavage can occur; if localization of the
proton is truly random, a complete series of fragment
ions desired for sequence interpretation may not be
forthcoming. In an effort to promote formation of a
complete series of ions, two approaches to a successful
analysis have been developed. One approach is to affix
a charge on one end of the peptide so that the fragmen-
tation will not depend on an incoming proton, but
rather will be due to intramolecular hydrogen shifts
within the precursor ion. The result is often termed
“charge-remote fragmentation” because cleavage of the
peptide bond occurs remote from the charge site [10].
The second approach uses chemical modification of
peptides to promote formation of a heterogenous pop-
ulation of precursor ions with respect to charge local-
ization. Using the latter approach, Keough et al. re-
cently reported on the sulfonation of the N-terminus to
aid in the increased mobility of the incoming proton
when analyzed by MALDI-PSD and ESI-CAD-MS/MS
[11, 12]. This follows from similar approaches where the
cysteine in a peptide, also containing a basic side
residue such as histidine, is oxidized to form cysteic
acid. The acidic and basic sites interact, which mini-
mizes fixation of the charge at the basic site. This results
in the formation of a precursor population with a
heterogeneous charge distribution [13].
Perspective on Fragmentation of Charged
Derivatives
Fixed-charge derivatives were initially developed for
FAB studies for purposes of increasing the hydropho-
bicity of the analyte [14]. Studies of these charged
derivatives continue by MALDI-PSD and ESI-CAD-
MS/MS for purposes of facilitating the formation of a
complete series of ions and simplification of the spec-
trum, because most fragment ions retain only the
charged terminus. Recent reports of the [tris (2,4,6-
trimethoxyphenyl) phosphonium] acetyl (TMPP1-Ac)
N-terminal derivatives of peptides show that charge-
remote fragmentation is indeed responsible for forma-
tion of a series of *an ions in FAB-CAD-MS [15],
MALDI-PSD-MS [16], and ESI-CAD-MS/MS [17]. The
fragmentation mechanisms of a related charged deriv-
ative, the triphenylphosphonium (TPP) derivatives,
have been studied by deuterium labeling and FAB-
CAD-MS [18]. Because such charged derivatives must
fragment by charge-remote mechanisms, there is a
sense that only high-energy CAD is a suitable technique
for their analysis; however, MALDI-PSD-MS and ESI-
CAD-MS/MS, which are not high-energy techniques,
have also been successful in promoting fragmentation
of these charged derivatives. In ESI-CAD, the charged
derivatives require higher energy for fragmentation
Figure 1. Previously proposed mechanisms of fragmentation of
protonated peptides to form bn and yn ions [7].
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than their underivatized counterparts, but still they can
be fragmented with application of less than 120 eV. This
is fortunate from a peptide sequencing standpoint be-
cause MALDI-PSD-MS and ESI-CAD-MS/MS tech-
niques are increasingly applied for the sequencing of
proteins/peptides. The energetic requirements in
MALDI-PSD-MS are still not very clear, but our studies
indicate that they are intermediate between those em-
ployed by conventional high-energy and low-energy
techniques.
During fragmentation of the charge-derivatized pep-
tide, there are three hydrogens [a, b, or the amide (h)
hydrogen as seen in Figure 2] that could undergo
intramolecular migration to yield fragment ions.
Results of previous studies suggest that the mecha-
nisms of charge-remote fragmentation are different
under low-energy and high-energy CAD. FAB-CAD
studies of TPP1-Ac derivatives of peptides suggest that
the b-hydrogen migrates to the neutral fragment as
shown in Figure 2b resulting in an *an ion [18]. If this
were the case, fragmentation at the site of glycine
(which lacks a b-hydrogen) should not be observed.
This is true for the TPP1-Ac peptides or TMPP1-Ac
peptides when analyzed by FAB-CAD. However, when
the TMPP1-Ac peptides are analyzed by MALDI-
PSD-MS or ESI-CAD-MS/MS fragmentation at glycine
is observed [16, 17]. Thus, migration of the b-hydrogen
is not the major pathway responsible for charge-remote
fragmentation of the charge-derivatized peptides when
analyzed by MALDI-PSD-MS or ESI-CAD-MS/MS.
These observations imply that the mechanisms of frag-
mentation are different for high-energy FAB-CAD-
MS/MS and low-energy ESI-CAD-MS/MS studies. An-
other important point is the absence of a signal relating
to cleavage at the site of proline (lacks an amide
hydrogen) that would produce an *an ion during anal-
ysis of the charged derivatives by MALDI-PSD-MS and
ESI-CAD-MS/MS; this result is consistent with the
requirement of an amide hydrogen shift for fragmenta-
tion. A previously proposed mechanism [16], involving
an amide hydrogen shift for fragmentation of charge-
derivatized peptides, is shown in Figure 2c.
Assessing Proposed Fragmentation
Mechanisms of Charged Derivatives with
Labeled Peptides
Our studies were designed to test the validity of some
previously proposed mechanisms for fragmentation of
charged derivatives of peptides. We prepared the
TMPP1-Ac derivatives of deuterium-labeled analogs of
VGVAPG and analyzed them by MALDI-PSD-MS or
ESI-CAD-MS/MS. In this paper, we describe results
from analyses of analogs of VGVAPG having deute-
rium labels at various sites, including selected a- and
b-carbons, and all available amide nitrogens (h-).
Experimental
Peptide Synthesis
Table 1 is a list of the deuterium-labeled analogs of
VGVAPG used in the study. The nonlabeled species (A)
and the labeled a- (B, C) and b- (D, E) were prepared
using solid-phase peptide synthesis techniques [19].
The amino acids with deuterium labels were purchased
from CDN isotopes (Canada). FMOC-protected amino
acids were used in the synthesis of the peptide during
Fastmoc cycles (HOBt/DCC) in an AP-Biosystems pep-
tide synthesizer. The molecular weight of the product
peptides was confirmed by MALDI-MS. The labeled
synthetic peptide was then derivatized directly with the
TMPP1-Ac reagent and subsequently purified by
HPLC.
The underivatized peptide with deuterium on the
amide nitrogen (F) was prepared by incubating the
peptide (VGVAPG) in D2O/deuterated acetonitrile (1:1
v/v) for 30 min to promote free exchange of the amide
hydrogens with deuterium. The derivatized peptide
having amide deuterons was prepared by first deriva-
tizing VGVAPG with the TMPP-Ac reagent and then
incubating the HPLC-purified peptide derivative in
D2O/deuterated acetonitrile.
Figure 2. (a) Hydrogens that could possibly shift during charge-
remote fragmentation of a peptide bond. (b) Left panel: Mecha-
nism of *an ion formation by b-hydrogen shift in charge-derivat-
ized peptides proposed by Wagner [18]. (c) Right panel:
Mechanism of *an ion formation by amide hydrogen shift in
TMPP1-Ac peptides by Liao [16].
Table 1. List of labeled peptides
Symbol Position of the deuterium label Peptide
A No label VGVAPG
B a-Carbon (glycine) VGaVAPG
C a-Carbon (valine) VaGVaAPG
D b-Carbon (valine) VbGVbAPG
E b-Carbon (alanine) VGVAbPG
F Amide nitrogen VhGhVhAhPGh
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Derivative Preparation
The TMPP1-Ac derivative of the peptides was prepared
by reacting 1 nmol of the peptide with a fivefold molar
excess of the derivatizing reagent (TMPP1-Ac-SC6F5;
synthesized as described in [15]) in the presence of
dimethylaminopyridine at room temperature for 15
min. The peptide derivative was separated from the
by-products and reagents using HPLC (conditions as
described in [17]).
Analyses by MALDI-MS
MALDI spectra were obtained with a Voyager Elite
reflectron time-of-flight mass spectrometer (Perseptive
Biosystems) using a 337-nm nitrogen laser and an
accelerating voltage of 22 kV. A saturated solution of
a-cyano-4-hydroxycinnamic acid, prepared in acetoni-
trile/water (1:1, v/v), was used as the matrix. A 1-mL
aliquot of the sample (1 pmol/mL) was mixed with an
equal volume of the matrix solution on the sample
plate, and the mixture dried in air. PSD data were
obtained with the mass spectrometer operated in the
reflectron mode. Several PSD spectra, each optimized
for a different range of m/z values for the fragment ions,
were obtained and “stitched” together to yield the
composite spectrum.
Analyses by ESI-CAD-MS/MS
A Finnigan LCQ (an ESI-ion trap mass spectrometer)
was used to obtain CAD information on the TMPP1-Ac
derivatives of the peptides (10 pmol/mL of acetonitrile/
water/1% acetic acid) by infusion of the sample (3
mL/min). The source was held at 4.3 kV, and helium
was used as the CAD gas for MS/MS. Fragmentation of
singly charged TMPP1-Ac derivatives occurred at rela-
tive collision energies of 60%–70% of a maximum of 5 V.
For in-source CAD, the source CAD option was turned
on, and typically, a setting of 50% was used for frag-
mentation.
Results
The peptide chosen for this study is VGVAPG, a che-
motactic peptide with no acidic or basic sidechains;
hence, fragmentation is simple. The peptide contains
proline, a residue without an amide hydrogen, a feature
that would provide us with additional insight regard-
ing the mechanisms of fragmentation. Furthermore,
VGVAPG is small enough to allow a good yield of the
fully deuterated amides during deuterium exchange
incubation.
Analysis of the Unlabeled TMPP1-Ac-VGVAPG
The mass spectral results from analysis of TMPP1-Ac-
VGVAPG by FAB-CAD-MS/MS, MALDI-PSD-MS, and
ESI-(source-CAD)-MS are shown in Figure 3a–c, re-
spectively; C1 in these mass spectra represents the
intact TMPP1-Ac peptide, which is a cation. It can be
seen that in the case of the FAB-CAD-MS/MS mass
spectrum (adapted from [16]), a signal is present for
cleavage at proline, whereas in the spectra from
MALDI-PSD-MS and ESI-(source-CAD)-MS/MS there
is no peak representing *a5. This observation suggests
that different mechanisms are operative for the genesis
of the *a5 ion from the charged derivative during
FAB-CAD-MS/MS (high-energy conditions) versus
during MALDI-PSD-MS or ESI-in-source-CAD-MS
(low-energy conditions).
The ESI-CAD-MS/MS spectrum of TMPP1-Ac-
VGVPAG, in an ion trap, is shown in Figure 3d. This
spectrum is different from that in Figure 3c, obtained
from ESI-source-CAD-MS. In Figure 3d, *bn ions are
also seen along with the *an ions. Most abundant are the
*an and *bn ions, except for cleavage at proline, where
the signal is weak compared to that for other ions. There
is a signal due to *a6 1 2 (m/z 1028). The other ions
observed are those that are 18 Da heavier than the *bn
ions; these are denoted as (*bn 1 H2O) ions.
In the following sections, results from analyses of all
labeled derivatives are summarized in designated ta-
bles for both *an and *bn ions.
Results from Analyses of Analogs with Deuterium
Label at the a-Carbon
Table 2 compares the m/z of the peaks observed for
TMPP1-Ac-VGVAPG (A) (the unlabeled species) with
those observed for TMPP1-Ac-VGaVAPG (B) (the a-la-
beled species) by ESI-(source-CAD)-MS, ESI-CAD-
MS/MS in the trap, and MALDI-PSD-MS.
In species B, only one of the glycines is labeled at the
a-carbon (two hydrogens) and hence the precursor
mass shifts by 2 Da (the C-terminal glycine is not
labeled because of limitations during peptide synthe-
sis). Thus, a mass shift of 2 Da will be observed for
fragment ions 2–6, when compared to the fragments
from the unlabeled species A, if the labels (deuterium
on the a-carbon) are retained during fragmentation. A
summary of peaks observed for *an and *bn ions is
listed in Table 2 for each of three different conditions. In
the MALDI-PSD spectrum, weak peaks due to *dn ions
for valine are observed; from the standpoint of frag-
mentation, these are formed from *an ions. To focus
more on the aspects of the formation of the major ions,
the *dn ions are not listed in Table 2.
In Table 2, it can be seen that the expected mass shifts
are observed corresponding to the retention of the
hydrogen on the a-carbon. These results indicate that
the mechanism of *an ion and *bn ion formation does
not involve a shift of hydrogen away from the a-carbon.
Results from analysis of the TMPP1-Ac derivatives of
the peptide labeled at the a-carbon of valine (species C)
were in agreement with these results; i.e., the mecha-
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nism of *an ion and *bn ion formation does not involve
the shift of hydrogen away from the a-carbon.
On the other hand, one need not consider all possible
hydrogens that can shift. For example, one would not
consider breaking two bonds to the same carbon (during
*an ion formation) as this would leave a carbene as a
resultant product. Such a consideration must be given to
the a-carbon, where migration of the hydrogen in ques-
tion and cleavage of the backbone at that site would
involve breaking two bonds attached to the same carbon.
Figure 3. (A) FAB-CAD-MS/MS spectrum of TMPP1-Ac-VGVPAG. (C1, here and in the other mass
spectra, represents the intact TMPP1-Ac peptide, which is a cation.) (B) MALDI-PSD-MS spectrum of
TMPP1-Ac-VGVPAG. (C) ESI-(source-CAD)-MS spectrum of TMPP1-Ac-VGVPAG. (D) ESI-CAD-
MS/MS spectrum of TMPP1-Ac-VGVPAG.
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Results from Analysis of Analogs with Deuterium
Labels at the b-Carbon
In order to investigate the fate of hydrogen on a
b-carbon atom in the TMPP1-Ac derivatized peptide, a
variant of the peptide with deuterium on the b-carbon
of valine was synthesized and studied by MALDI-
PSD-MS and ESI-CAD-MS/MS. Although observations
suggest that the migration of this b-hydrogen is not the
most plausible mechanism (because signal due to cleav-
age at glycine, which lacks a b-hydrogen, is observed),
it is yet to be proven.
In Table 3, because the b-hydrogen is labeled in both
the valines, the fragment ions 1–2 are expected to have
a shift of 1 Da, whereas the fragment ions 3–6 are
expected to have a shift of 2 Da, if the deuterium label
is retained on the b-carbon.
As listed in Table 3, the mass shifts indicate retention of
the deuterium label on the b-carbon. The glycine residue,
which lacks a b-hydrogen, does undergo fragmentation
and a signal (*a2) is observed for cleavage at glycine during
analysis by MALDI-PSD-MS and ESI-CAD-MS/MS.
Similarly, a d3 analog of VGAVPG containing three
deuterons on the methyl group of alanine (species E)
was synthesized and its TMPP1-Ac derivative analyzed
by MALDI-PSD and ESI-CAD-MS/MS. The results
showed that the fragment ions do retain the deuterium
label on the b-carbon of the alanine residue.
These results corroborate those obtained from the
Table 2. Ions observed for d2-TMPP
1-Ac-VGaVAPG (B)
Ion type Unlabeled (A)
a-G labeled (B)
(CAD-MS/MS)
a-G labeled (B)
(source-CAD-MS)
a-G labeled (B)
(MALDI-PSD-MS)
*a1 644 644 644 644
*b1 672 672 none none
*a2 701 703 703 703
*b2 729 731 none none
*a3 800 802 802 802
*b3 828 830 none none
*a4 871 873 873 873
*b4 899 901 none none
*a5
# 968 970 none none
*b5
# 996 998 none none
*a6 1 2 1027 1029 1029 1029
*b6 1053 1055 none none
#Only observed during CAD-MS/MS in the ion trap mass spectrometer.
Table 3. Ions observed for d2-TMPP
1-Ac-VbGVbAPG (D)
Ion type
Unlabeled (A)
(CAD-MS/MS)
b-V labeled (D)
(CAD-MS/MS)
b-V labeled (D)
(MALDI-PSD-MS)
*a1 644 645 645
*b1 672 673 none
*a2 701 702 702
*b2 729 730 none
*a3 800 802 802
*b3 828 830 none
*a4 871 873 873
*b4 899 901 none
*a5 968 970 none
*b5 996 998 none
*a6 1 2 1027 1029 1029
*b6 1053 1055 none
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study of the derivative where the b-carbon of valine
(species D) is labeled. Thus, when the TMPP1-Ac
peptides are analyzed by MALDI-PSD-MS and ESI-
CAD-MS/MS, the major fragmentation pathway does
not involve a b-hydrogen shift.
Results from Analyses of Peptides with Deuterium
Label on the Amide Nitrogens
The acidic hydrogens of a peptide (–CONH, COOH,
and NH2) are readily exchangeable with those of the
surrounding solvent molecules; thus, TMPP1-Ac-
VGVAPG has six acidic hydrogens (five amide hydro-
gens plus one carboxylic hydrogen).
During ESI-CAD-MS/MS, the infusion/sample de-
livery line in the ESI mass spectrometer was flushed
with the deuterated solvents to ensure that the ex-
changed deuterium on the peptide remains intact. Dur-
ing CAD-MS/MS, the completely deuterated precursor
was selected, m/z 1077.4 6 .02. Figure 4 shows the
full-scan mass spectrum of d6-TMPP
1-Ac-VGVAPG
(species F). The overall deuterium incorporation at all
six expected sites is relatively high [relative intensities
(%) of the other species (d5, d4) are only 30% and 10%,
respectively].
The structure diagram at the top of Table 4 indicates
the expected mass of the fragment ions if the deuterium
label on the amide is retained (i.e., if there is no shift of
an amide deuteron). However, the results (Table 4)
show fragment ions detected one mass unit lower than
the expected value for ions *a1 through *a4. These
results suggest that in the formation of ions *a1 through
*a4, there is a shift of the amide hydrogen.
Discussions
Based on the results obtained from analysis of the
deuterium analogs of TMPP1-Ac-VGVAPG by MALDI-
PSD-MS or ESI-CAD-MS/MS, various mechanisms pro-
posed by other researchers are either experimentally
confirmed or new mechanisms based on our experi-
mental evidence are proposed.
Mechanism of Formation of the *an Ion Due to the
Shift of an Amide Hydrogen
As stated at the outset, there are only three local
hydrogens that could shift during the fragmentation
process, namely, those located on the a-carbon, b-car-
bon, or the h-nitrogen. The results shown earlier sug-
gest that there is no observed shift of the a- or b-hy-
drogens. The results from analyses of species F, where
the amide nitrogen is labeled with deuterium, suggest
that it is the amide hydrogen that is involved in the
formation of the *an fragment ions when the TMPP
1-Ac
analogs of a peptide are analyzed by MALDI-PSD-MS
or ESI-CAD-MS/MS. These observations serve as ex-
perimental evidence for the plausible mechanism pro-
posed earlier by Liao et al. for fragmentation of the
TMPP1-Ac peptides during MALDI-PSD-MS [16]. The
Figure 4. ESI-MS spectrum of d6-TMPP
1-Ac-hVhGhVhAhPGh.
Table 4. Ions observed for d6-TMPP
1-Ac-VhGhVhAhPGh (F)
Ion type
Unlabeled
(A)
Amide-hydrogen labeled (F)
(CAD-MS/MS)
Amide-hydrogen labeled (F)
(MALDI-PSD-MS)
*a1 644 644 644
*b1 672 672 none
*a2 701 702 702
*b2 729 730 none
*a3 800 802 802
*b3 828 830 none
*a4 871 874 874
*b4 899 902 none
*a5 968 972 none
*b5 996 999 none
*a6 1 2 1027 1033 1033
*b6 1053 1057 none
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pathway involving the shift of the amide hydrogen was
shown in Figure 2c. The same mechanism also appears
to be responsible for fragmentation by ESI-CAD-
MS/MS for most situations.
Mechanism for Formation of the (*a6 1 2) Ion Due
to the Shift of the C-terminal Hydrogen Atom
During the fragmentation of the TMPP1-Ac-VGVAPG,
a peak appears corresponding to the mass of an *a6 1 2
ion instead of an *a6 ion. A mechanism that may explain
the origin of the *a6 1 2 ion has been proposed earlier
by Liao et al. [16]; our results serve as evidence for such
a mechanism.
During the analysis of the amide-labeled species (F),
one would expect a peak at m/z 1032 (expected mass is
1027 1 5 Da) for the (*a6 1 2), but the peak appears at
m/z 1033. These types of ions are formed only in cases
where there is a free carboxy terminus. The fact that
there is a larger than expected mass shift (1033 Da
instead of 1032 Da) suggests that one of the two
additional hydrogens on the (*a6 1 2) is a deuteron,
which originates from the carboxy terminus as shown
in Figure 5 (adapted from [16]).
Mechanism for Formation of the *bn Ion Due to
the Shift of an Amide Hydrogen
The results from the study of the amide deuterium-
labeled species (F) suggest that *bn ions are formed
from the shift of amide hydrogens. One of the previ-
ously proposed structures for a *bn ion is a ketene as
shown in Figure 6 [18].
If the structure in Figure 6 is accurate, then our
results from the current study should show retention of
the deuterium label on the nitrogen, and the mass
difference between a *bn ion and an *an ion would be 29
Da. However, the mass of the *bn ions is only 28 Da
higher than that of the corresponding *an ions. Results
from analysis of peptide derivatives with a deuterium
label on the a-carbon (Table 2) suggest that the a-hy-
drogen is retained during formation of the *bn ion.
However, the a-hydrogen in the *bn ion represented by
Figure 6 is lost. Hence, in concert with the experimental
results, a new structure for a *bn ion is proposed,
possibly in the form of an aziridinone, in which the
a-hydrogen is retained, but the amide hydrogen is lost.
The mechanism of formation of an aziridinone is shown
in Figure 7a, which suggests the loss of the amide
hydrogen and retention of the a-hydrogen during the
formation of the *bn ion.
An alternative possible structure, taking into account
loss of the local amide hydrogen during formation of
the *bn ion, is an oxazalone. A possible mechanism for
generating an oxazalone is shown in Figure 7b. The
oxazalone structure for bn ions formed from protonated
peptides has been proposed by Yalcin et al. [20]. Even
though the oxazalone structure for b1 ions cannot be
derived from protonated peptides, it is possible to form
the *b1 ion from TMPP
1-Ac peptides because of the
presence of an acetyl linkage between the charged
moiety and the amino terminus.
Mechanism for Loss of the C-terminal Residue
Loss of the terminal glycine residue is observed in data
obtained by both MALDI-PSD-MS and ESI-CAD-MS/
MS. This loss of the C-terminus has been typically
observed in cases where it is a free carboxy functional-
ity [21], from which the authors suggest that the –OH
group shifts to the neighboring amide carbonyl, result-
ing in the loss of the terminal residue. If this mechanism
Figure 5. Mechanism for formation of the terminal (*an 1 2) ion
[16].
Figure 6. Structure of a *bn ion [18].
Figure 7. (a) and (b) Mechanisms for formation of the *bn ion
during ESI-CAD-MS/MS in an ion trap mass spectrometer.
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(proposed by Thorne et al.) were true, the resulting
fragment (which had lost the terminal residue and,
hence, one deuterium label on its amide nitrogen) from
the amide deuterium-labeled species (F) would still be
shifted by 5 Da (four deuterons on amide nitrogens of
residues 1–4, plus the one shifting from the C-termi-
nus), correspondingly. A shift of 5 Da is observed, and
the fragment has a mass of 1019 Da from the deuterium-
exchanged species (F), whereas the mass of the frag-
ment arising from the unlabeled species is only 1014 Da.
The mechanism adapted from [21] for the TMPP1-Ac-
VGVAPG (species F) for the loss of C-terminal glycine is
shown in Figure 8.
Genesis of *an and *bn ions Due to Cleavage at the
Site of the Proline Residue
The ESI-CAD-MS/MS and MALDI-PSD-MS results
from analysis of the TMPP1-Ac derivatives of the
labeled peptides suggest that the major fragmentation
pathway in the formation of *an and *bn ions is due to
a shift of the amide hydrogen over to the neutral
fragment of the peptide as shown in Figure 2b. Thus, a
signal for the *an and *bn ions due to cleavage at
proline, the amino acid which lacks an amide hydrogen,
cannot be expected. Yet, in the ESI-CAD-MS/MS spec-
tra, there is always a low intensity signal at the m/z
values corresponding to the *an and *bn ions. Table 5
concisely presents the m/z values of the *a5 and *b5 peaks
observed for the various labeled and unlabeled species.
The shift in mass for *a5 and *b5 from the species
with deuterium labels at the a-carbon (B, C) or the
b-carbon (D, E) suggests that these hydrogens do not
shift during formation of these ions. However, data
from analyses of the amide hydrogen-labeled species
are different (compare row 7 with row 2). For the *a5
ion, if there were no shift of amide hydrogens, the mass
of the labeled fragment ion (972 Da) should be 4 Da
greater than that of the fragment ion (968 Da) formed
from the unlabeled species. This expectation is in agree-
ment with the observed result, which suggests that the
fragmentation process does not involve the amide hy-
drogens of any of the neighboring residues. Based on
these results, the most likely way to obtain the *a5 ion
involves transfer of a hydrogen from the cyclic
sidechain of proline (b-hydrogen shift) as shown in
Figure 9. Such a pathway is not the most predominant
in low-energy CAD, and may not be favored energeti-
cally; hence, a very weak signal is observed (,10% of
the relative intensity of the base peak). However, the
fact that there is a signal is intriguing, and the results
from mass spectrometric analysis of the labeled pep-
tides prove the validity of this signal. This type of
b-hydrogen shift is primarily responsible for fragmen-
tation during analysis by high-energy CAD-MS/MS.
The data from Table 5 also indicate that in the case of
the formation of the *b5 ion, the shift in mass in the case
of the amide-labeled peptide and the unlabeled peptide
is not 4 Da (as observed for the *a5 ion), but only 3 Da.
Figure 8. Mechanism for formation of the C1-G fragment from
TMPP1-Ac-VGVAPG [21].
Table 5. List of m/z values for *a5 and *b5 ions observed from
the labeled variants of TMPP1-Ac-VGVAPG
Peptide *a5 *b5
(1)-VGVAPG (A) 968 996
(1)-VGaVAPG (B) 970 998
(1)-VaGVaAPG (C) 970 998
(1)-VbGVbAPG (D) 970 998
(1)-VGVAbPG (E) 971 999
(1)-hVhGhVhAPhG (F) 972 999
Figure 9. Mechanism for formation of the *a5 ion due to cleavage
at the proline residue.
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This observation suggests that one of the deuterons on
the amide nitrogen from the neighboring residue is
possibly shifted away resulting in the formation of the
*b5 ion. A reasonable mechanism (a similar mechanism
for the formation of *bn ion from a multiply protonated
peptide has been proposed by Tang and Boyd [22])
depicting this process is shown in Figure 10. This
pathway involves a six-centered intermediate, and
forms a six-membered ring (diketopiperazine), which is
a stable system. This is a more stable structure than the
structure of the *a5 ion, which may explain why the
signal due to the *b5 ion is slightly larger than the signal
due to *a5 (;12% of the base peak).
The above discussions indicate that the formation of
the *a5 ion does not involve a shift of the amide
hydrogen, whereas the formation of the *b5 ion in-
volves a shift of a neighboring amide hydrogen.
Conclusions
The results obtained during a study of the TMPP1-Ac
(charged) derivatives of deuterium-labeled peptides
provide insight to the major mechanisms responsible
for fragmentation of these charge-derivatized peptides
during MALDI-PSD-MS and ESI-CAD-MS/MS. The
results from the mass spectrometric study of the
TMPP1-Ac derivatives of deuterium-labeled analogs of
VGVAPG serve as evidence for a previously proposed
mechanism (Liao et al. [16]). This mechanism involves
shift of the amide hydrogen of the residue at which the
cleavage occurs during the formation of the *an and the
*bn ions. The results also suggest that the structure of
the *bn ion is probably not a ketone as suggested
previously, but may be an aziridinone or an oxazalone.
The data serve as evidence for a previously proposed
mechanism for the loss of the C-terminal residue
(Thorne et al. [21]). Minor signal due to the cleavage at
the proline residue suggests that ions do form due to
cleavage at this site during ESI-CAD-MS/MS in an ion
trap, although there is no amide hydrogen present. The
shift in masses for the fragment ion *a5 (from the
amide-hydrogen labeled species of TMPP1-Ac-
VGVAPG) implies that the ion formation due to cleav-
age at proline involves a hydrogen shift from the ring
structure of the sidechain in proline (a b-hydrogen
shift). However, the *b5 ion is formed by the shift of a
neighboring amide hydrogen to produce a structure
consisting of a six-membered ring.
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